600867.SH
通化东宝
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 7.95
−1.97%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- CNY 0.08
- Revenue estimate
- CNY 850.2M
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- CNY 0.09
- EPS estimate
- CNY 0.06
- Revenue actual
- CNY 796.6M
- Revenue estimate
- CNY 813.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +50.0%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026